Global Pet Inactivated Vaccine Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Pet Inactivated Vaccine market size is predicted to grow from US$ 554 million in 2025 to US$ 777 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.
Inactivated vaccines for pets are vaccines made from killed pathogens.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly Ђ6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 377%.
LP Information, Inc. (LPI) ' newest research report, the “Pet Inactivated Vaccine Industry Forecast” looks at past sales and reviews total world Pet Inactivated Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Pet Inactivated Vaccine sales for 2025 through 2031. With Pet Inactivated Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet Inactivated Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Pet Inactivated Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet Inactivated Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pet Inactivated Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet Inactivated Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet Inactivated Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Inactivated Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Pet Inactivated Vaccine market?
What factors are driving Pet Inactivated Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pet Inactivated Vaccine market opportunities vary by end market size?
How does Pet Inactivated Vaccine break out by Type, by Application?
The global Pet Inactivated Vaccine market size is predicted to grow from US$ 554 million in 2025 to US$ 777 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.
Inactivated vaccines for pets are vaccines made from killed pathogens.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly Ђ6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 377%.
LP Information, Inc. (LPI) ' newest research report, the “Pet Inactivated Vaccine Industry Forecast” looks at past sales and reviews total world Pet Inactivated Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Pet Inactivated Vaccine sales for 2025 through 2031. With Pet Inactivated Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet Inactivated Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Pet Inactivated Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet Inactivated Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pet Inactivated Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet Inactivated Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet Inactivated Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Inactivated Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Obtained by Heat Killing
- Killed by Chemical Methods such as Formaldehyde
- Obtained by Radiation Killing
- Dog
- Cat
- Dird
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer Healthcare
- Vetoquinol S.A
- Boehringer Ingelheim
- Ceva
- Eli Lilly
- Heska
- Merck Animal Health
- Merial (Sanofi)
- Virbac
- Pfizer
What is the 10-year outlook for the global Pet Inactivated Vaccine market?
What factors are driving Pet Inactivated Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pet Inactivated Vaccine market opportunities vary by end market size?
How does Pet Inactivated Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pet Inactivated Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pet Inactivated Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pet Inactivated Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Pet Inactivated Vaccine Segment by Type
2.2.1 Obtained by Heat Killing
2.2.2 Killed by Chemical Methods such as Formaldehyde
2.2.3 Obtained by Radiation Killing
2.3 Pet Inactivated Vaccine Sales by Type
2.3.1 Global Pet Inactivated Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Pet Inactivated Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pet Inactivated Vaccine Sale Price by Type (2020-2025)
2.4 Pet Inactivated Vaccine Segment by Application
2.4.1 Dog
2.4.2 Cat
2.4.3 Dird
2.4.4 Others
2.5 Pet Inactivated Vaccine Sales by Application
2.5.1 Global Pet Inactivated Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Pet Inactivated Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pet Inactivated Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Pet Inactivated Vaccine Breakdown Data by Company
3.1.1 Global Pet Inactivated Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Pet Inactivated Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Pet Inactivated Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Pet Inactivated Vaccine Revenue by Company (2020-2025)
3.2.2 Global Pet Inactivated Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Pet Inactivated Vaccine Sale Price by Company
3.4 Key Manufacturers Pet Inactivated Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Inactivated Vaccine Product Location Distribution
3.4.2 Players Pet Inactivated Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PET INACTIVATED VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Pet Inactivated Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Pet Inactivated Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pet Inactivated Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pet Inactivated Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Pet Inactivated Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pet Inactivated Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pet Inactivated Vaccine Sales Growth
4.4 APAC Pet Inactivated Vaccine Sales Growth
4.5 Europe Pet Inactivated Vaccine Sales Growth
4.6 Middle East & Africa Pet Inactivated Vaccine Sales Growth
5 AMERICAS
5.1 Americas Pet Inactivated Vaccine Sales by Country
5.1.1 Americas Pet Inactivated Vaccine Sales by Country (2020-2025)
5.1.2 Americas Pet Inactivated Vaccine Revenue by Country (2020-2025)
5.2 Americas Pet Inactivated Vaccine Sales by Type (2020-2025)
5.3 Americas Pet Inactivated Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Inactivated Vaccine Sales by Region
6.1.1 APAC Pet Inactivated Vaccine Sales by Region (2020-2025)
6.1.2 APAC Pet Inactivated Vaccine Revenue by Region (2020-2025)
6.2 APAC Pet Inactivated Vaccine Sales by Type (2020-2025)
6.3 APAC Pet Inactivated Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pet Inactivated Vaccine by Country
7.1.1 Europe Pet Inactivated Vaccine Sales by Country (2020-2025)
7.1.2 Europe Pet Inactivated Vaccine Revenue by Country (2020-2025)
7.2 Europe Pet Inactivated Vaccine Sales by Type (2020-2025)
7.3 Europe Pet Inactivated Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pet Inactivated Vaccine by Country
8.1.1 Middle East & Africa Pet Inactivated Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pet Inactivated Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Pet Inactivated Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Pet Inactivated Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Inactivated Vaccine
10.3 Manufacturing Process Analysis of Pet Inactivated Vaccine
10.4 Industry Chain Structure of Pet Inactivated Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Inactivated Vaccine Distributors
11.3 Pet Inactivated Vaccine Customer
12 WORLD FORECAST REVIEW FOR PET INACTIVATED VACCINE BY GEOGRAPHIC REGION
12.1 Global Pet Inactivated Vaccine Market Size Forecast by Region
12.1.1 Global Pet Inactivated Vaccine Forecast by Region (2026-2031)
12.1.2 Global Pet Inactivated Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pet Inactivated Vaccine Forecast by Type (2026-2031)
12.7 Global Pet Inactivated Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bayer Healthcare
13.1.1 Bayer Healthcare Company Information
13.1.2 Bayer Healthcare Pet Inactivated Vaccine Product Portfolios and Specifications
13.1.3 Bayer Healthcare Pet Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bayer Healthcare Main Business Overview
13.1.5 Bayer Healthcare Latest Developments
13.2 Vetoquinol S.A
13.2.1 Vetoquinol S.A Company Information
13.2.2 Vetoquinol S.A Pet Inactivated Vaccine Product Portfolios and Specifications
13.2.3 Vetoquinol S.A Pet Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Vetoquinol S.A Main Business Overview
13.2.5 Vetoquinol S.A Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Pet Inactivated Vaccine Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Pet Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Ceva
13.4.1 Ceva Company Information
13.4.2 Ceva Pet Inactivated Vaccine Product Portfolios and Specifications
13.4.3 Ceva Pet Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Ceva Main Business Overview
13.4.5 Ceva Latest Developments
13.5 Eli Lilly
13.5.1 Eli Lilly Company Information
13.5.2 Eli Lilly Pet Inactivated Vaccine Product Portfolios and Specifications
13.5.3 Eli Lilly Pet Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Eli Lilly Main Business Overview
13.5.5 Eli Lilly Latest Developments
13.6 Heska
13.6.1 Heska Company Information
13.6.2 Heska Pet Inactivated Vaccine Product Portfolios and Specifications
13.6.3 Heska Pet Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Heska Main Business Overview
13.6.5 Heska Latest Developments
13.7 Merck Animal Health
13.7.1 Merck Animal Health Company Information
13.7.2 Merck Animal Health Pet Inactivated Vaccine Product Portfolios and Specifications
13.7.3 Merck Animal Health Pet Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Merck Animal Health Main Business Overview
13.7.5 Merck Animal Health Latest Developments
13.8 Merial (Sanofi)
13.8.1 Merial (Sanofi) Company Information
13.8.2 Merial (Sanofi) Pet Inactivated Vaccine Product Portfolios and Specifications
13.8.3 Merial (Sanofi) Pet Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Merial (Sanofi) Main Business Overview
13.8.5 Merial (Sanofi) Latest Developments
13.9 Virbac
13.9.1 Virbac Company Information
13.9.2 Virbac Pet Inactivated Vaccine Product Portfolios and Specifications
13.9.3 Virbac Pet Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Virbac Main Business Overview
13.9.5 Virbac Latest Developments
13.10 Pfizer
13.10.1 Pfizer Company Information
13.10.2 Pfizer Pet Inactivated Vaccine Product Portfolios and Specifications
13.10.3 Pfizer Pet Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Pfizer Main Business Overview
13.10.5 Pfizer Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Pet Inactivated Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pet Inactivated Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Obtained by Heat Killing
Table 4. Major Players of Killed by Chemical Methods such asFormaldehyde
Table 5. Major Players of Obtained by Radiation Killing
Table 6. Global Pet Inactivated Vaccine Sales byType (2020-2025) & (K Units)
Table 7. Global Pet Inactivated Vaccine Sales Market Share byType (2020-2025)
Table 8. Global Pet Inactivated Vaccine Revenue byType (2020-2025) & ($ million)
Table 9. Global Pet Inactivated Vaccine Revenue Market Share byType (2020-2025)
Table 10. Global Pet Inactivated Vaccine Sale Price byType (2020-2025) & (US$/Unit)
Table 11. Global Pet Inactivated Vaccine Sale by Application (2020-2025) & (K Units)
Table 12. Global Pet Inactivated Vaccine Sale Market Share by Application (2020-2025)
Table 13. Global Pet Inactivated Vaccine Revenue by Application (2020-2025) & ($ million)
Table 14. Global Pet Inactivated Vaccine Revenue Market Share by Application (2020-2025)
Table 15. Global Pet Inactivated Vaccine Sale Price by Application (2020-2025) & (US$/Unit)
Table 16. Global Pet Inactivated Vaccine Sales by Company (2020-2025) & (K Units)
Table 17. Global Pet Inactivated Vaccine Sales Market Share by Company (2020-2025)
Table 18. Global Pet Inactivated Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Pet Inactivated Vaccine Revenue Market Share by Company (2020-2025)
Table 20. Global Pet Inactivated Vaccine Sale Price by Company (2020-2025) & (US$/Unit)
Table 21. Key Manufacturers Pet Inactivated Vaccine Producing Area Distribution and Sales Area
Table 22. Players Pet Inactivated Vaccine Products Offered
Table 23. Pet Inactivated Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Pet Inactivated Vaccine Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Pet Inactivated Vaccine Sales Market Share Geographic Region (2020-2025)
Table 28. Global Pet Inactivated Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Pet Inactivated Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Pet Inactivated Vaccine Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Pet Inactivated Vaccine Sales Market Share by Country/Region (2020-2025)
Table 32. Global Pet Inactivated Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Pet Inactivated Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Pet Inactivated Vaccine Sales by Country (2020-2025) & (K Units)
Table 35. Americas Pet Inactivated Vaccine Sales Market Share by Country (2020-2025)
Table 36. Americas Pet Inactivated Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Pet Inactivated Vaccine Sales byType (2020-2025) & (K Units)
Table 38. Americas Pet Inactivated Vaccine Sales by Application (2020-2025) & (K Units)
Table 39. APAC Pet Inactivated Vaccine Sales by Region (2020-2025) & (K Units)
Table 40. APAC Pet Inactivated Vaccine Sales Market Share by Region (2020-2025)
Table 41. APAC Pet Inactivated Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Pet Inactivated Vaccine Sales byType (2020-2025) & (K Units)
Table 43. APAC Pet Inactivated Vaccine Sales by Application (2020-2025) & (K Units)
Table 44. Europe Pet Inactivated Vaccine Sales by Country (2020-2025) & (K Units)
Table 45. Europe Pet Inactivated Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Pet Inactivated Vaccine Sales byType (2020-2025) & (K Units)
Table 47. Europe Pet Inactivated Vaccine Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Pet Inactivated Vaccine Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Pet Inactivated Vaccine Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Pet Inactivated Vaccine Sales byType (2020-2025) & (K Units)
Table 51. Middle East & Africa Pet Inactivated Vaccine Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Pet Inactivated Vaccine
Table 53. Key Market Challenges & Risks of Pet Inactivated Vaccine
Table 54. Key IndustryTrends of Pet Inactivated Vaccine
Table 55. Pet Inactivated Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Pet Inactivated Vaccine Distributors List
Table 58. Pet Inactivated Vaccine Customer List
Table 59. Global Pet Inactivated Vaccine SalesForecast by Region (2026-2031) & (K Units)
Table 60. Global Pet Inactivated Vaccine RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Pet Inactivated Vaccine SalesForecast by Country (2026-2031) & (K Units)
Table 62. Americas Pet Inactivated Vaccine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Pet Inactivated Vaccine SalesForecast by Region (2026-2031) & (K Units)
Table 64. APAC Pet Inactivated Vaccine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Pet Inactivated Vaccine SalesForecast by Country (2026-2031) & (K Units)
Table 66. Europe Pet Inactivated Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Pet Inactivated Vaccine SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Pet Inactivated Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Pet Inactivated Vaccine SalesForecast byType (2026-2031) & (K Units)
Table 70. Global Pet Inactivated Vaccine RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Pet Inactivated Vaccine SalesForecast by Application (2026-2031) & (K Units)
Table 72. Global Pet Inactivated Vaccine RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Bayer Healthcare Basic Information, Pet Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. Bayer Healthcare Pet Inactivated Vaccine Product Portfolios and Specifications
Table 75. Bayer Healthcare Pet Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Bayer Healthcare Main Business
Table 77. Bayer Healthcare Latest Developments
Table 78. Vetoquinol S.A Basic Information, Pet Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Vetoquinol S.A Pet Inactivated Vaccine Product Portfolios and Specifications
Table 80. Vetoquinol S.A Pet Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Vetoquinol S.A Main Business
Table 82. Vetoquinol S.A Latest Developments
Table 83. Boehringer Ingelheim Basic Information, Pet Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Boehringer Ingelheim Pet Inactivated Vaccine Product Portfolios and Specifications
Table 85. Boehringer Ingelheim Pet Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Boehringer Ingelheim Main Business
Table 87. Boehringer Ingelheim Latest Developments
Table 88. Ceva Basic Information, Pet Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Ceva Pet Inactivated Vaccine Product Portfolios and Specifications
Table 90. Ceva Pet Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Ceva Main Business
Table 92. Ceva Latest Developments
Table 93. Eli Lilly Basic Information, Pet Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Eli Lilly Pet Inactivated Vaccine Product Portfolios and Specifications
Table 95. Eli Lilly Pet Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Eli Lilly Main Business
Table 97. Eli Lilly Latest Developments
Table 98. Heska Basic Information, Pet Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Heska Pet Inactivated Vaccine Product Portfolios and Specifications
Table 100. Heska Pet Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Heska Main Business
Table 102. Heska Latest Developments
Table 103. Merck Animal Health Basic Information, Pet Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Merck Animal Health Pet Inactivated Vaccine Product Portfolios and Specifications
Table 105. Merck Animal Health Pet Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Merck Animal Health Main Business
Table 107. Merck Animal Health Latest Developments
Table 108. Merial (Sanofi) Basic Information, Pet Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Merial (Sanofi) Pet Inactivated Vaccine Product Portfolios and Specifications
Table 110. Merial (Sanofi) Pet Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. Merial (Sanofi) Main Business
Table 112. Merial (Sanofi) Latest Developments
Table 113. Virbac Basic Information, Pet Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Virbac Pet Inactivated Vaccine Product Portfolios and Specifications
Table 115. Virbac Pet Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. Virbac Main Business
Table 117. Virbac Latest Developments
Table 118. Pfizer Basic Information, Pet Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Pfizer Pet Inactivated Vaccine Product Portfolios and Specifications
Table 120. Pfizer Pet Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 121. Pfizer Main Business
Table 122. Pfizer Latest Developments
LIST OFFIGURES
Figure 1. Picture of Pet Inactivated Vaccine
Figure 2. Pet Inactivated Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet Inactivated Vaccine Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Pet Inactivated Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pet Inactivated Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pet Inactivated Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Pet Inactivated Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Obtained by Heat Killing
Figure 12. Product Picture of Killed by Chemical Methods such asFormaldehyde
Figure 13. Product Picture of Obtained by Radiation Killing
Figure 14. Global Pet Inactivated Vaccine Sales Market Share byType in 2025
Figure 15. Global Pet Inactivated Vaccine Revenue Market Share byType (2020-2025)
Figure 16. Pet Inactivated Vaccine Consumed in Dog
Figure 17. Global Pet Inactivated Vaccine Market: Dog (2020-2025) & (K Units)
Figure 18. Pet Inactivated Vaccine Consumed in Cat
Figure 19. Global Pet Inactivated Vaccine Market: Cat (2020-2025) & (K Units)
Figure 20. Pet Inactivated Vaccine Consumed in Dird
Figure 21. Global Pet Inactivated Vaccine Market: Dird (2020-2025) & (K Units)
Figure 22. Pet Inactivated Vaccine Consumed in Others
Figure 23. Global Pet Inactivated Vaccine Market: Others (2020-2025) & (K Units)
Figure 24. Global Pet Inactivated Vaccine Sale Market Share by Application (2024)
Figure 25. Global Pet Inactivated Vaccine Revenue Market Share by Application in 2025
Figure 26. Pet Inactivated Vaccine Sales by Company in 2025 (K Units)
Figure 27. Global Pet Inactivated Vaccine Sales Market Share by Company in 2025
Figure 28. Pet Inactivated Vaccine Revenue by Company in 2025 ($ millions)
Figure 29. Global Pet Inactivated Vaccine Revenue Market Share by Company in 2025
Figure 30. Global Pet Inactivated Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Pet Inactivated Vaccine Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Pet Inactivated Vaccine Sales 2020-2025 (K Units)
Figure 33. Americas Pet Inactivated Vaccine Revenue 2020-2025 ($ millions)
Figure 34. APAC Pet Inactivated Vaccine Sales 2020-2025 (K Units)
Figure 35. APAC Pet Inactivated Vaccine Revenue 2020-2025 ($ millions)
Figure 36. Europe Pet Inactivated Vaccine Sales 2020-2025 (K Units)
Figure 37. Europe Pet Inactivated Vaccine Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Pet Inactivated Vaccine Sales 2020-2025 (K Units)
Figure 39. Middle East & Africa Pet Inactivated Vaccine Revenue 2020-2025 ($ millions)
Figure 40. Americas Pet Inactivated Vaccine Sales Market Share by Country in 2025
Figure 41. Americas Pet Inactivated Vaccine Revenue Market Share by Country (2020-2025)
Figure 42. Americas Pet Inactivated Vaccine Sales Market Share byType (2020-2025)
Figure 43. Americas Pet Inactivated Vaccine Sales Market Share by Application (2020-2025)
Figure 44. United States Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Pet Inactivated Vaccine Sales Market Share by Region in 2025
Figure 49. APAC Pet Inactivated Vaccine Revenue Market Share by Region (2020-2025)
Figure 50. APAC Pet Inactivated Vaccine Sales Market Share byType (2020-2025)
Figure 51. APAC Pet Inactivated Vaccine Sales Market Share by Application (2020-2025)
Figure 52. China Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. India Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 58. ChinaTaiwan Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Pet Inactivated Vaccine Sales Market Share by Country in 2025
Figure 60. Europe Pet Inactivated Vaccine Revenue Market Share by Country (2020-2025)
Figure 61. Europe Pet Inactivated Vaccine Sales Market Share byType (2020-2025)
Figure 62. Europe Pet Inactivated Vaccine Sales Market Share by Application (2020-2025)
Figure 63. Germany Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64.France Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Pet Inactivated Vaccine Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Pet Inactivated Vaccine Sales Market Share byType (2020-2025)
Figure 70. Middle East & Africa Pet Inactivated Vaccine Sales Market Share by Application (2020-2025)
Figure 71. Egypt Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 74.Turkey Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Pet Inactivated Vaccine in 2025
Figure 77. Manufacturing Process Analysis of Pet Inactivated Vaccine
Figure 78. Industry Chain Structure of Pet Inactivated Vaccine
Figure 79. Channels of Distribution
Figure 80. Global Pet Inactivated Vaccine Sales MarketForecast by Region (2026-2031)
Figure 81. Global Pet Inactivated Vaccine Revenue Market ShareForecast by Region (2026-2031)
Figure 82. Global Pet Inactivated Vaccine Sales Market ShareForecast byType (2026-2031)
Figure 83. Global Pet Inactivated Vaccine Revenue Market ShareForecast byType (2026-2031)
Figure 84. Global Pet Inactivated Vaccine Sales Market ShareForecast by Application (2026-2031)
Figure 85. Global Pet Inactivated Vaccine Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pet Inactivated Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pet Inactivated Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pet Inactivated Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Pet Inactivated Vaccine Segment by Type
2.2.1 Obtained by Heat Killing
2.2.2 Killed by Chemical Methods such as Formaldehyde
2.2.3 Obtained by Radiation Killing
2.3 Pet Inactivated Vaccine Sales by Type
2.3.1 Global Pet Inactivated Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Pet Inactivated Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pet Inactivated Vaccine Sale Price by Type (2020-2025)
2.4 Pet Inactivated Vaccine Segment by Application
2.4.1 Dog
2.4.2 Cat
2.4.3 Dird
2.4.4 Others
2.5 Pet Inactivated Vaccine Sales by Application
2.5.1 Global Pet Inactivated Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Pet Inactivated Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pet Inactivated Vaccine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Pet Inactivated Vaccine Breakdown Data by Company
3.1.1 Global Pet Inactivated Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Pet Inactivated Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Pet Inactivated Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Pet Inactivated Vaccine Revenue by Company (2020-2025)
3.2.2 Global Pet Inactivated Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Pet Inactivated Vaccine Sale Price by Company
3.4 Key Manufacturers Pet Inactivated Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Inactivated Vaccine Product Location Distribution
3.4.2 Players Pet Inactivated Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PET INACTIVATED VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Pet Inactivated Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Pet Inactivated Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pet Inactivated Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pet Inactivated Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Pet Inactivated Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pet Inactivated Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pet Inactivated Vaccine Sales Growth
4.4 APAC Pet Inactivated Vaccine Sales Growth
4.5 Europe Pet Inactivated Vaccine Sales Growth
4.6 Middle East & Africa Pet Inactivated Vaccine Sales Growth
5 AMERICAS
5.1 Americas Pet Inactivated Vaccine Sales by Country
5.1.1 Americas Pet Inactivated Vaccine Sales by Country (2020-2025)
5.1.2 Americas Pet Inactivated Vaccine Revenue by Country (2020-2025)
5.2 Americas Pet Inactivated Vaccine Sales by Type (2020-2025)
5.3 Americas Pet Inactivated Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Inactivated Vaccine Sales by Region
6.1.1 APAC Pet Inactivated Vaccine Sales by Region (2020-2025)
6.1.2 APAC Pet Inactivated Vaccine Revenue by Region (2020-2025)
6.2 APAC Pet Inactivated Vaccine Sales by Type (2020-2025)
6.3 APAC Pet Inactivated Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pet Inactivated Vaccine by Country
7.1.1 Europe Pet Inactivated Vaccine Sales by Country (2020-2025)
7.1.2 Europe Pet Inactivated Vaccine Revenue by Country (2020-2025)
7.2 Europe Pet Inactivated Vaccine Sales by Type (2020-2025)
7.3 Europe Pet Inactivated Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pet Inactivated Vaccine by Country
8.1.1 Middle East & Africa Pet Inactivated Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pet Inactivated Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Pet Inactivated Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Pet Inactivated Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Inactivated Vaccine
10.3 Manufacturing Process Analysis of Pet Inactivated Vaccine
10.4 Industry Chain Structure of Pet Inactivated Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Inactivated Vaccine Distributors
11.3 Pet Inactivated Vaccine Customer
12 WORLD FORECAST REVIEW FOR PET INACTIVATED VACCINE BY GEOGRAPHIC REGION
12.1 Global Pet Inactivated Vaccine Market Size Forecast by Region
12.1.1 Global Pet Inactivated Vaccine Forecast by Region (2026-2031)
12.1.2 Global Pet Inactivated Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pet Inactivated Vaccine Forecast by Type (2026-2031)
12.7 Global Pet Inactivated Vaccine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bayer Healthcare
13.1.1 Bayer Healthcare Company Information
13.1.2 Bayer Healthcare Pet Inactivated Vaccine Product Portfolios and Specifications
13.1.3 Bayer Healthcare Pet Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bayer Healthcare Main Business Overview
13.1.5 Bayer Healthcare Latest Developments
13.2 Vetoquinol S.A
13.2.1 Vetoquinol S.A Company Information
13.2.2 Vetoquinol S.A Pet Inactivated Vaccine Product Portfolios and Specifications
13.2.3 Vetoquinol S.A Pet Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Vetoquinol S.A Main Business Overview
13.2.5 Vetoquinol S.A Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Pet Inactivated Vaccine Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Pet Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Ceva
13.4.1 Ceva Company Information
13.4.2 Ceva Pet Inactivated Vaccine Product Portfolios and Specifications
13.4.3 Ceva Pet Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Ceva Main Business Overview
13.4.5 Ceva Latest Developments
13.5 Eli Lilly
13.5.1 Eli Lilly Company Information
13.5.2 Eli Lilly Pet Inactivated Vaccine Product Portfolios and Specifications
13.5.3 Eli Lilly Pet Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Eli Lilly Main Business Overview
13.5.5 Eli Lilly Latest Developments
13.6 Heska
13.6.1 Heska Company Information
13.6.2 Heska Pet Inactivated Vaccine Product Portfolios and Specifications
13.6.3 Heska Pet Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Heska Main Business Overview
13.6.5 Heska Latest Developments
13.7 Merck Animal Health
13.7.1 Merck Animal Health Company Information
13.7.2 Merck Animal Health Pet Inactivated Vaccine Product Portfolios and Specifications
13.7.3 Merck Animal Health Pet Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Merck Animal Health Main Business Overview
13.7.5 Merck Animal Health Latest Developments
13.8 Merial (Sanofi)
13.8.1 Merial (Sanofi) Company Information
13.8.2 Merial (Sanofi) Pet Inactivated Vaccine Product Portfolios and Specifications
13.8.3 Merial (Sanofi) Pet Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Merial (Sanofi) Main Business Overview
13.8.5 Merial (Sanofi) Latest Developments
13.9 Virbac
13.9.1 Virbac Company Information
13.9.2 Virbac Pet Inactivated Vaccine Product Portfolios and Specifications
13.9.3 Virbac Pet Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Virbac Main Business Overview
13.9.5 Virbac Latest Developments
13.10 Pfizer
13.10.1 Pfizer Company Information
13.10.2 Pfizer Pet Inactivated Vaccine Product Portfolios and Specifications
13.10.3 Pfizer Pet Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Pfizer Main Business Overview
13.10.5 Pfizer Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Pet Inactivated Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pet Inactivated Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Obtained by Heat Killing
Table 4. Major Players of Killed by Chemical Methods such asFormaldehyde
Table 5. Major Players of Obtained by Radiation Killing
Table 6. Global Pet Inactivated Vaccine Sales byType (2020-2025) & (K Units)
Table 7. Global Pet Inactivated Vaccine Sales Market Share byType (2020-2025)
Table 8. Global Pet Inactivated Vaccine Revenue byType (2020-2025) & ($ million)
Table 9. Global Pet Inactivated Vaccine Revenue Market Share byType (2020-2025)
Table 10. Global Pet Inactivated Vaccine Sale Price byType (2020-2025) & (US$/Unit)
Table 11. Global Pet Inactivated Vaccine Sale by Application (2020-2025) & (K Units)
Table 12. Global Pet Inactivated Vaccine Sale Market Share by Application (2020-2025)
Table 13. Global Pet Inactivated Vaccine Revenue by Application (2020-2025) & ($ million)
Table 14. Global Pet Inactivated Vaccine Revenue Market Share by Application (2020-2025)
Table 15. Global Pet Inactivated Vaccine Sale Price by Application (2020-2025) & (US$/Unit)
Table 16. Global Pet Inactivated Vaccine Sales by Company (2020-2025) & (K Units)
Table 17. Global Pet Inactivated Vaccine Sales Market Share by Company (2020-2025)
Table 18. Global Pet Inactivated Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Pet Inactivated Vaccine Revenue Market Share by Company (2020-2025)
Table 20. Global Pet Inactivated Vaccine Sale Price by Company (2020-2025) & (US$/Unit)
Table 21. Key Manufacturers Pet Inactivated Vaccine Producing Area Distribution and Sales Area
Table 22. Players Pet Inactivated Vaccine Products Offered
Table 23. Pet Inactivated Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Pet Inactivated Vaccine Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Pet Inactivated Vaccine Sales Market Share Geographic Region (2020-2025)
Table 28. Global Pet Inactivated Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Pet Inactivated Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Pet Inactivated Vaccine Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Pet Inactivated Vaccine Sales Market Share by Country/Region (2020-2025)
Table 32. Global Pet Inactivated Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Pet Inactivated Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Pet Inactivated Vaccine Sales by Country (2020-2025) & (K Units)
Table 35. Americas Pet Inactivated Vaccine Sales Market Share by Country (2020-2025)
Table 36. Americas Pet Inactivated Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Pet Inactivated Vaccine Sales byType (2020-2025) & (K Units)
Table 38. Americas Pet Inactivated Vaccine Sales by Application (2020-2025) & (K Units)
Table 39. APAC Pet Inactivated Vaccine Sales by Region (2020-2025) & (K Units)
Table 40. APAC Pet Inactivated Vaccine Sales Market Share by Region (2020-2025)
Table 41. APAC Pet Inactivated Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Pet Inactivated Vaccine Sales byType (2020-2025) & (K Units)
Table 43. APAC Pet Inactivated Vaccine Sales by Application (2020-2025) & (K Units)
Table 44. Europe Pet Inactivated Vaccine Sales by Country (2020-2025) & (K Units)
Table 45. Europe Pet Inactivated Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Pet Inactivated Vaccine Sales byType (2020-2025) & (K Units)
Table 47. Europe Pet Inactivated Vaccine Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Pet Inactivated Vaccine Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Pet Inactivated Vaccine Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Pet Inactivated Vaccine Sales byType (2020-2025) & (K Units)
Table 51. Middle East & Africa Pet Inactivated Vaccine Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Pet Inactivated Vaccine
Table 53. Key Market Challenges & Risks of Pet Inactivated Vaccine
Table 54. Key IndustryTrends of Pet Inactivated Vaccine
Table 55. Pet Inactivated Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Pet Inactivated Vaccine Distributors List
Table 58. Pet Inactivated Vaccine Customer List
Table 59. Global Pet Inactivated Vaccine SalesForecast by Region (2026-2031) & (K Units)
Table 60. Global Pet Inactivated Vaccine RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Pet Inactivated Vaccine SalesForecast by Country (2026-2031) & (K Units)
Table 62. Americas Pet Inactivated Vaccine Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Pet Inactivated Vaccine SalesForecast by Region (2026-2031) & (K Units)
Table 64. APAC Pet Inactivated Vaccine Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Pet Inactivated Vaccine SalesForecast by Country (2026-2031) & (K Units)
Table 66. Europe Pet Inactivated Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Pet Inactivated Vaccine SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Pet Inactivated Vaccine RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Pet Inactivated Vaccine SalesForecast byType (2026-2031) & (K Units)
Table 70. Global Pet Inactivated Vaccine RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Pet Inactivated Vaccine SalesForecast by Application (2026-2031) & (K Units)
Table 72. Global Pet Inactivated Vaccine RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Bayer Healthcare Basic Information, Pet Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. Bayer Healthcare Pet Inactivated Vaccine Product Portfolios and Specifications
Table 75. Bayer Healthcare Pet Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Bayer Healthcare Main Business
Table 77. Bayer Healthcare Latest Developments
Table 78. Vetoquinol S.A Basic Information, Pet Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Vetoquinol S.A Pet Inactivated Vaccine Product Portfolios and Specifications
Table 80. Vetoquinol S.A Pet Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Vetoquinol S.A Main Business
Table 82. Vetoquinol S.A Latest Developments
Table 83. Boehringer Ingelheim Basic Information, Pet Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Boehringer Ingelheim Pet Inactivated Vaccine Product Portfolios and Specifications
Table 85. Boehringer Ingelheim Pet Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Boehringer Ingelheim Main Business
Table 87. Boehringer Ingelheim Latest Developments
Table 88. Ceva Basic Information, Pet Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Ceva Pet Inactivated Vaccine Product Portfolios and Specifications
Table 90. Ceva Pet Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Ceva Main Business
Table 92. Ceva Latest Developments
Table 93. Eli Lilly Basic Information, Pet Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Eli Lilly Pet Inactivated Vaccine Product Portfolios and Specifications
Table 95. Eli Lilly Pet Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Eli Lilly Main Business
Table 97. Eli Lilly Latest Developments
Table 98. Heska Basic Information, Pet Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Heska Pet Inactivated Vaccine Product Portfolios and Specifications
Table 100. Heska Pet Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Heska Main Business
Table 102. Heska Latest Developments
Table 103. Merck Animal Health Basic Information, Pet Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Merck Animal Health Pet Inactivated Vaccine Product Portfolios and Specifications
Table 105. Merck Animal Health Pet Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Merck Animal Health Main Business
Table 107. Merck Animal Health Latest Developments
Table 108. Merial (Sanofi) Basic Information, Pet Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Merial (Sanofi) Pet Inactivated Vaccine Product Portfolios and Specifications
Table 110. Merial (Sanofi) Pet Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. Merial (Sanofi) Main Business
Table 112. Merial (Sanofi) Latest Developments
Table 113. Virbac Basic Information, Pet Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Virbac Pet Inactivated Vaccine Product Portfolios and Specifications
Table 115. Virbac Pet Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. Virbac Main Business
Table 117. Virbac Latest Developments
Table 118. Pfizer Basic Information, Pet Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Pfizer Pet Inactivated Vaccine Product Portfolios and Specifications
Table 120. Pfizer Pet Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 121. Pfizer Main Business
Table 122. Pfizer Latest Developments
LIST OFFIGURES
Figure 1. Picture of Pet Inactivated Vaccine
Figure 2. Pet Inactivated Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet Inactivated Vaccine Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Pet Inactivated Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pet Inactivated Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pet Inactivated Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Pet Inactivated Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Obtained by Heat Killing
Figure 12. Product Picture of Killed by Chemical Methods such asFormaldehyde
Figure 13. Product Picture of Obtained by Radiation Killing
Figure 14. Global Pet Inactivated Vaccine Sales Market Share byType in 2025
Figure 15. Global Pet Inactivated Vaccine Revenue Market Share byType (2020-2025)
Figure 16. Pet Inactivated Vaccine Consumed in Dog
Figure 17. Global Pet Inactivated Vaccine Market: Dog (2020-2025) & (K Units)
Figure 18. Pet Inactivated Vaccine Consumed in Cat
Figure 19. Global Pet Inactivated Vaccine Market: Cat (2020-2025) & (K Units)
Figure 20. Pet Inactivated Vaccine Consumed in Dird
Figure 21. Global Pet Inactivated Vaccine Market: Dird (2020-2025) & (K Units)
Figure 22. Pet Inactivated Vaccine Consumed in Others
Figure 23. Global Pet Inactivated Vaccine Market: Others (2020-2025) & (K Units)
Figure 24. Global Pet Inactivated Vaccine Sale Market Share by Application (2024)
Figure 25. Global Pet Inactivated Vaccine Revenue Market Share by Application in 2025
Figure 26. Pet Inactivated Vaccine Sales by Company in 2025 (K Units)
Figure 27. Global Pet Inactivated Vaccine Sales Market Share by Company in 2025
Figure 28. Pet Inactivated Vaccine Revenue by Company in 2025 ($ millions)
Figure 29. Global Pet Inactivated Vaccine Revenue Market Share by Company in 2025
Figure 30. Global Pet Inactivated Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Pet Inactivated Vaccine Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Pet Inactivated Vaccine Sales 2020-2025 (K Units)
Figure 33. Americas Pet Inactivated Vaccine Revenue 2020-2025 ($ millions)
Figure 34. APAC Pet Inactivated Vaccine Sales 2020-2025 (K Units)
Figure 35. APAC Pet Inactivated Vaccine Revenue 2020-2025 ($ millions)
Figure 36. Europe Pet Inactivated Vaccine Sales 2020-2025 (K Units)
Figure 37. Europe Pet Inactivated Vaccine Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Pet Inactivated Vaccine Sales 2020-2025 (K Units)
Figure 39. Middle East & Africa Pet Inactivated Vaccine Revenue 2020-2025 ($ millions)
Figure 40. Americas Pet Inactivated Vaccine Sales Market Share by Country in 2025
Figure 41. Americas Pet Inactivated Vaccine Revenue Market Share by Country (2020-2025)
Figure 42. Americas Pet Inactivated Vaccine Sales Market Share byType (2020-2025)
Figure 43. Americas Pet Inactivated Vaccine Sales Market Share by Application (2020-2025)
Figure 44. United States Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Pet Inactivated Vaccine Sales Market Share by Region in 2025
Figure 49. APAC Pet Inactivated Vaccine Revenue Market Share by Region (2020-2025)
Figure 50. APAC Pet Inactivated Vaccine Sales Market Share byType (2020-2025)
Figure 51. APAC Pet Inactivated Vaccine Sales Market Share by Application (2020-2025)
Figure 52. China Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. India Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 58. ChinaTaiwan Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Pet Inactivated Vaccine Sales Market Share by Country in 2025
Figure 60. Europe Pet Inactivated Vaccine Revenue Market Share by Country (2020-2025)
Figure 61. Europe Pet Inactivated Vaccine Sales Market Share byType (2020-2025)
Figure 62. Europe Pet Inactivated Vaccine Sales Market Share by Application (2020-2025)
Figure 63. Germany Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64.France Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Pet Inactivated Vaccine Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Pet Inactivated Vaccine Sales Market Share byType (2020-2025)
Figure 70. Middle East & Africa Pet Inactivated Vaccine Sales Market Share by Application (2020-2025)
Figure 71. Egypt Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 74.Turkey Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Pet Inactivated Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Pet Inactivated Vaccine in 2025
Figure 77. Manufacturing Process Analysis of Pet Inactivated Vaccine
Figure 78. Industry Chain Structure of Pet Inactivated Vaccine
Figure 79. Channels of Distribution
Figure 80. Global Pet Inactivated Vaccine Sales MarketForecast by Region (2026-2031)
Figure 81. Global Pet Inactivated Vaccine Revenue Market ShareForecast by Region (2026-2031)
Figure 82. Global Pet Inactivated Vaccine Sales Market ShareForecast byType (2026-2031)
Figure 83. Global Pet Inactivated Vaccine Revenue Market ShareForecast byType (2026-2031)
Figure 84. Global Pet Inactivated Vaccine Sales Market ShareForecast by Application (2026-2031)
Figure 85. Global Pet Inactivated Vaccine Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Paroxetine Hydrochloride Market Growth 2025-2031
US$ 3,660.00
October 2025
94 pages
Global Rear-Wheel Drive Power Wheelchairs Market Growth 2024-2030
US$ 3,660.00
December 2024
115 pages
Global Angong Niuhuang Pill Market Growth 2024-2030
US$ 3,660.00
December 2024
114 pages
Global Efficacy Testing Instrument Market Growth 2024-2030
US$ 3,660.00
February 2024
106 pages
